Cancer Archive — Page 28 of 71

Ayaka Sugiura and Jeff Rathmell, PhD, are studying a metabolic enzyme involved in T cell function that may offer a new target for anti-inflammatory therapeutics.
November 11, 2021

CRISPR screen identifies new anti-inflammatory drug target

A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics.

By Leigh MacMillan
Portrait of a smiling bald man wearing glasses, a dark blue checked suit, white shirt, and striped tie.
November 4, 2021

Koerkenmeier named VICC associate nursing officer

By Tom Wilemon
Wooden bowl filled with assorted nuts, including almonds, pecans, walnuts, pistachios, and hazelnuts, with more nuts scattered on a light surface.
November 1, 2021

Breast cancer survivors: eat nuts

Breast cancer survivors who reported eating nuts regularly had 50% reduced risk of breast cancer recurrence, metastasis or mortality, Vanderbilt epidemiologists found in Shanghai Breast Cancer Survival Study.

By Leigh MacMillan
Exterior of Vanderbilt-Ingram Cancer Center’s Frances Williams Preston Building, a brick-and-glass research building with a covered entrance and elevated pedestrian bridge.
October 28, 2021

V Foundation to support study of pediatric soft tissue sarcoma

By Doug Campbell
Head-and-shoulders portrait of a smiling woman in a white lab coat standing in a laboratory with shelves and equipment in the background. The coat embroidery identifies her as Ingrid Mayer, MD, MSCI.
October 28, 2021

VICC’s Mayer departing to take new role with AstraZeneca

Ingrid Mayer, MD, MSCI, is departing Vanderbilt University Medical Center for a new role as an executive with AstraZeneca.

By Tom Wilemon
A new robot with a flexible camera and three different surgical instruments will allow more targeted surgeries for patients with head and neck cancers.
October 21, 2021

New robot enhances accuracy of head, neck cancer surgeries

By Emily Stembridge